Targets of anti-influenza chemotherapy other than neuraminidase and proton pump

Antiviral Chemistry and Chemotherapy, Supplement

Volumn 12, Issue 1, 2001, Pages 179-188

  Shigeta, S ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti influenza drug; Fusion inhibitor; Haemagglutinin; Resistant strain; Transcription inhibitor

Indexed keywords

1,2,4 TRIAZOLE CARBOXAMIDE; 180299; 2,4 DIOXOBUTANOIC ACID; 4 [1 BENZYL 3 (4 CHLOROBENZYL) 3 PIPERIDINYL] 2,4 DIOXOBUTYRIC ACID; AMANTADINE; AMITIVIR; ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; BAFILOMYCIN A1; BMY 26270; BMY 27709; CAMOSTAT MESILATE; CAPPED RNA; CL 38509; CROFELEMER; FLUTIMIDE; HEMAGGLUTININ; HYDROQUINON; HYDROXAMIC ACID; LIGNIN; LUNG SURFACTANT; M QUINOLIZINE BENZAMIDE; MANGANESE SUPEROXIDE DISMUTASE; PEPTIDE 6; PM 523; PODOCARPIC ACID DERIVATIVE; POLYOXOMETALATE; PROTON PUMP INHIBITOR; RIBAVIRIN; SIALIDASE INHIBITOR; SYNTHETIC POLYPHENOL; TBHQ; TRIPERIDENE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL MODEL; CELL MEMBRANE; CONFERENCE PAPER; DRUG EFFICACY; ENZYME ACTIVITY; INFLUENZA; INFLUENZA VIRUS; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS ADSORPTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; HUMANS; MEMBRANE FUSION; MICE; NEURAMINIDASE; ORTHOMYXOVIRIDAE; PROTON PUMPS; RIBAVIRIN; RNA, VIRAL; TRANSCRIPTION, GENETIC;

ANIMALIA; INFLUENZA VIRUS; MEASLES VIRUS; RESPIRATORY SYNCYTIAL VIRUS; SYNCYTIAL VIRUS;

EID: 0034804529     PISSN: 13502816     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells
2. Identification of N-hydroxamic acid and N-hydroxyimide compounds that inhibit the influenza virus polymerase
3. Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase
4. Approaches and strategies for the treatment of influenza virus infections
5. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
6. SP-303 small-particle aerosol treatment of influenza A virus infection in mice and respiratory syncytial virus infection in cotton rats
7. The clinical pharmacology of ribavirin
8. Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors
9. Efficacy and safety of the NA inhibitor zanamivir in the treatment of influenza virus infection
10. Structure based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: Irreversible inhibition of infectivity
11. Comparative inhibitory effects of various nucleoside and nucleotide analogues on replication of influenza virus type A and B in vitro and in vivo
12. Serological evidence for prevention of influenza infection in volunteers by anti-influenzal drug adamantanamine hydrochloride
13. In vivo anti-influenza virus acitivity of a zinc finger peptide
14. Pulmonary surfectant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus
15. Ribavirin small-particle aerosol treatment of influenza
16. The relationship between the metabolism of ribavirin and its proposed mechanism of action
17. Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A
18. Synthetic polymeric inhibitors of influenza virus receptor binding activity. Suppress virus replication
19. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
20. Effect of hochu-ekkito (TJ41), a Japanese herbal medicine, on the survival of mice infected with influenza virus
21. Efficacy and safety of oseltamivir in treatment of acute influenza: A randomized controlled trial
22. Pharmacokinetics of ribavirin and urinary excretion of the major metabolite 1,2,4-triazole-3-caroboxamide in normal volunteers
23. Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin
24. Effect of intramuscularly injected polyprenols on influenza virus infection in mice
25. Anti-influenza virus activity of a lignin fraction from cone of Pinus parviflora Sieb. Et Zucc.
26. Influenza virus - Inhibitory effects of intraperitonealy and aerosol-administered SP-303, a plant flavonoid
27. Inhibitory effect of recombinant manganese superoxide dismutase on influenza virus infection in mice
28. In vitro antimyxovirus activity and mechanism of anti-influenzavirus activity of polyoxometalates PM504 and PM-523
29. Recent progress in anti-influenza chemotherapy
30. Randomized trial of efficacy and safety of inhaled zanamivir treatment of influenza A and B infections
31. Inhibition of influenza virus hemagglutinin mediated membrane fusion by a compound related to podocarpic acid
32. A novel antiviral agent which inhibits the endonuclease of influenza virus
33. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza
34. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal dose of influenza virus
35. 183WNMR and X-ray chrystallographic studies on the peroxo complexes of the Ti substituted a-Keggin typed tungstophosphates